$132.74
-1.17[-0.87%]
At close: Apr 24
$132.74
0[0.00%]
After Hours: 4:00PM EDT
Latest News for DaVita Stock (NYSE:DVA)
DaVita Stock (NYSE: DVA)
Categories: All
Tuesday, April 23, 2024
Tuesday, April 09, 2024
Friday, April 05, 2024
Thursday, April 04, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
- Why Are Dialysis Provider Stocks Trading Higher On Tuesday?Vandana Singh - Mar 5, 2024, 3:21PM
- Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Mar 5, 2024, 1:11PM
- NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Mar 5, 2024, 10:56AM
- Shares of dialysis stocks are trading higher in reaction to Novo Nordisk's Ozempic kidney disease data.Benzinga Newsdesk - Mar 5, 2024, 10:17AM
- DaVita Enters Into Agreement To Expand Operations In Brazil And Colombia, Enter Chile And Ecuador, Involving Four Separate Acquisitions From Fresenius Medical Care For A Total Purchase Price Of $300MBenzinga Newsdesk - Mar 5, 2024, 9:07AM
Thursday, February 29, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
Tuesday, February 20, 2024
Wednesday, February 14, 2024
- Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Feb 14, 2024, 10:36AM
- DaVita shares are trading higher after the company reported better-than-expected Q4 financial results.Benzinga Newsdesk - Feb 14, 2024, 8:43AM
- Truist Securities Maintains Hold on DaVita, Raises Price Target to $130Benzinga Newsdesk - Feb 14, 2024, 8:15AM
Tuesday, February 13, 2024
- DaVita Expects 2024 Adjusted EPS Of $8.70-$9.80, Est $8.68Benzinga Newsdesk - Feb 13, 2024, 4:44PM
- DaVita: Q4 Earnings InsightsBenzinga Insights - Feb 13, 2024, 4:30PM
- DaVita Q4 Adj EPS $1.87 Beats $1.59 Estimate, Sales $3.15B Beat $3.01B EstimateBenzinga Newsdesk - Feb 13, 2024, 4:13PM
- Earnings Scheduled For February 13, 2024Benzinga Insights - Feb 13, 2024, 5:05AM
Monday, February 12, 2024
Wednesday, January 31, 2024
Tuesday, December 19, 2023
Friday, November 17, 2023
Monday, November 13, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
- DaVita: Q3 Earnings InsightsBenzinga Insights - Nov 7, 2023, 4:30PM
- DaVita Raises FY23 Adj. EPS Guidance From $7.00-$7.80 To $7.80-$8.30 vs $7.21 Est.; Raises Adj. Operating Income Guidance From $1.565B-$1.675B To $1.65B-$1.725BBenzinga Newsdesk - Nov 7, 2023, 4:27PM
- DaVita Q3 Adj $2.85 Beats $2.02 Estimate, Sales $3.10B Beat $3.02B EstimateBenzinga Newsdesk - Nov 7, 2023, 4:25PM
- Check Out What Whales Are Doing With DVABenzinga Insights - Nov 7, 2023, 2:45PM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Thursday, October 19, 2023
Thursday, October 12, 2023
- Ozempic Ingredient Gives Novo Nordisk's Kidney Trial A Positive Result: What It Means For Health CareAdam Eckert - Oct 12, 2023, 12:23PM
- Fresenius Medical Care Tells Reuters In Statement That Novo Nordisk's Ozempic And Other GLP-1 Drugs May Slow The Progression Of Chronic Kidney Disease, But Overall Mortality Of Treated Individuals Would Also Be ReducedBenzinga Newsdesk - Oct 12, 2023, 12:00PM
- DaVita Unusual Options ActivityBenzinga Insights - Oct 12, 2023, 11:03AM
- DaVita Statement on GLP-1 And Potential Implications On Chronic Kidney DiseaseBenzinga Newsdesk - Oct 12, 2023, 8:35AM
Wednesday, October 11, 2023
- Truist Securities Maintains Hold on DaVita, Lowers Price Target to $104Benzinga Newsdesk - Oct 11, 2023, 3:58PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Oct 11, 2023, 1:31PM
- Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Oct 11, 2023, 1:13PM
- Stocks In The Red, Bonds On The Rise As Investors Brace for FOMC Minutes, Crucial CPI Report: What's Driving Markets Wednesday?Shanthi Rexaline - Oct 11, 2023, 1:10PM
- Shares of dialysis providers and kidney care stocks are trading lower after Novo Nordisk stopped its semaglutide kidney outcomes trial early based on early signs of efficacy.Bill Haddad - Oct 11, 2023, 11:03AM
- What's Going On With Kidney Dialysis Provider Stocks Today?Vandana Singh - Oct 11, 2023, 9:52AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Oct 11, 2023, 9:06AM
- Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 11, 2023, 8:24AM
- Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionLisa Levin - Oct 11, 2023, 6:00AM